Macherey-Nagel GmbH & Co. KG and Andrew Alliance Sign Co-Marketing Agreement

Monday, February 4, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

GENEVA, February 4, 2019 /PRNewswire/ --

Macherey-Nagel GmbH & Co. KG and Andrew Alliance

today announced they have signed an agreement stating that they are working together to develop an automated solution for the preparation of transfection grade plasmid DNA.  Under the co-marketing agreement, Macherey-Nagel will combine its existing NucleoBondŽ
Xtra Midi kits with Andrew Alliance's OneLab software platform and Andrew+ robot.

"Dr. Achim Leitzke (General Manager Sales and Marketing, MACHEREY-NAGEL, Germany) stated "Biotechnology in general and biomedical and biopharmaceutical research in particular are increasingly moving towards workflow automation, freeing up valuable human resources for creative and productive work. Further, reliability and traceability are gaining in importance. As a pioneer in the technology of nucleic acid purification, MACHEREY-NAGEL has extensive experience in automated plasmid preps. Likewise, throughout the years, we have always provided innovative solutions and state of the art methods in the field of plasmid midi processing based on anion exchange chromatography. In order to remain on the cutting edge of a rapidly evolving market, we need a reliable and competent automation partner. We believe that we have found such a partner in Andrew Alliance and that together, our experts can develop a truly great product for automated plasmid midi prep processing."

Piero Zucchelli, CEO and Co-Founder of Andrew Alliance stated, "Having transfection grade plasmid DNA available is critical to many of today's high value biopharmaceutical applications.  Working with Macherey-Nagel and their proven anion-exchange technology will allow us to develop a cost effective automation solution for this important process."

For more information about the Macherey-Nagel NucleoBondŽ technology, visit http://www.mn-net.com

For more information about Andrew Alliance, OneLab and the Andrew+, please contact contact@andrewalliance.com       

SOURCE Andrew Alliance SA



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store